Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600380's Gross Margin % is ranked better than 73.19% of 940
companies
in the Drug Manufacturers industry
Industry Median: 48.35
vs SHSE:600380: 62.78
Joincare Pharmaceutical Group Industry Co had a gross margin of 63.19% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Joincare Pharmaceutical Group Industry Co (SHSE:600380) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Joincare Pharmaceutical Group Industry Co had a gross margin of 63.19% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Joincare Pharmaceutical Group Industry Co Gross Margin % Related Terms
Joincare Pharmaceutical Group Industry Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co Gross Margin % Chart
Joincare Pharmaceutical Group Industry Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joincare Pharmaceutical Group Industry Co Gross Margin % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Joincare Pharmaceutical Group Industry Co (SHSE:600380) has a Gross Margin % of 63.19% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. This is near median its historical median of 62.76. Over the past decade, Joincare Pharmaceutical Group Industry Co's Gross Margin % has ranged from 62.16 to 64.35. According to the industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #252 out of 940 companies in the Drug Manufacturers industry, placing it in the top 26.8%.
Is Joincare Pharmaceutical Group Industry Co's Gross Margin % too high?
Joincare Pharmaceutical Group Industry Co's current Gross Margin % of 63.19% is near median its 10-year median of 62.76. Over the past 10 years, this metric has ranged from a low of 62.16 to a high of 64.35. The Drug Manufacturers industry median Gross Margin % is 48.35. Joincare Pharmaceutical Group Industry Co's value of 63.19% is 30.7% above this industry median. Based on the distribution chart, Joincare Pharmaceutical Group Industry Co ranks #252 out of 940 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #252 out of 940 companies for Gross Margin %. This puts Joincare Pharmaceutical Group Industry Co in the upper half of its industry. The industry median Gross Margin % is 48.35. Joincare Pharmaceutical Group Industry Co's value of 63.19% is 30.7% above this benchmark. Historically, Joincare Pharmaceutical Group Industry Co's own Gross Margin % has ranged from 62.16 to 64.35 over the past decade. While the company's 10-year median is 62.76 vs. the industry median of 48.35, Joincare Pharmaceutical Group Industry Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.35, based on 940 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joincare Pharmaceutical Group Industry Co's current Gross Margin % of 63.19% is 30.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joincare Pharmaceutical Group Industry Co's current Gross Margin % is 63.19%, which is near median its own 10-year median of 62.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co (SHSE:600380) is currently considered Fairly Valued. The stock's GF Value™ is ¥11.11, compared to a current price of ¥10.44 — trading 6% below its estimated fair value. The current Gross Margin % is 63.19%, which is near median its 10-year median of 62.76 and 30.7% above the Drug Manufacturers industry median of 48.35. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (SHSE:600380), the current Gross Margin % is 63.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joincare Pharmaceutical Group Industry Co (SHSE:600380) Overvalued in 2026?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued.
The current stock price of ¥10.44 is trading 6% below its estimated GF Value™ of ¥11.11.
GuruFocus considers Joincare Pharmaceutical Group Industry Co to be Fairly Valued.
Key valuation signals for SHSE:600380:
Gross Margin %: 63.19% (near median its 10-year median of 62.76)
GF Value™: ¥11.11 vs. price of ¥10.44 (6% below fair value)
Industry Position: 30.7% above the Drug Manufacturers median (#252 of 940)
No single metric tells the full story. See the SHSE:600380 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score
Get the complete analysis for SHSE:600380
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600380 has been successfully added to your 
